or Try an Advanced Search...

    U.S. Food And Drug Administration Stocks List

    Symbol Grade Name % Change
    SBIO D ALPS Medical Breakthroughs ETF -2.35
    BWAY C Brainsway Ltd. -2.20
    CYTK D Cytokinetics, Incorporated -3.00
    DRRX D DURECT Corporation -6.19
    ETON F Eton Pharmaceutcials, Inc. -0.15
    LSTA D Lisata Therapeutics, Inc. 1.27
    PLRX F Pliant Therapeutics, Inc. 0.00
    SNPX F Synaptogenix, Inc. -2.97
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Biopharmaceutical Neuroscience Pharmaceutical Amyotrophic Lateral Sclerosis Biotechnology Disease Drug Design FDA Medicine Multiple Sclerosis Opioids Orphan Drug Pain Stroke Acid Addiction Adhd Alcohol Allergic Conjunctivitis Alzheimer's Disease

    Related ETFs - A few ETFs which own one or more of the above listed U.S. Food And Drug Administration stocks.

    Symbol Grade Name Weight
    HRTS D Tema Cardiovascular and Metabolic ETF 2.93
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 2.03
    BTEC D Principal Healthcare Innovators Index ETF 1.6
    XBI D SPDR S&P Biotech ETF 1.06
    BBH B Market Vectors Biotech ETF 0.86
    View all U.S. Food And Drug Administration ETFs...
    Compare ETFs
    Compare BTEC to BBH Compare BTEC to XBI Compare HRTS to BBC

        U.S. Food And Drug Administration Stocks Recent News

        Date Stock Title
        May 10 LSTA Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q1 2024 Earnings Call Transcript
        May 10 CYTK Cytokinetics Inc (CYTK) Reports Q1 2024 Earnings: Widening Losses Amid Expansive Clinical Trials
        May 10 LSTA Q1 2024 Lisata Therapeutics Inc Earnings Call
        May 10 ETON Q1 2024 Eton Pharmaceuticals Inc Earnings Call
        May 10 CYTK Cytokinetics First Quarter 2024 Earnings: Misses Expectations
        May 10 LSTA Lisata Therapeutics, Inc. (LSTA) Q1 2024 Earnings Call Transcript
        May 9 LSTA Lisata Therapeutics Net Loss Declines From a Year Earlier
        May 9 LSTA Lisata Therapeutics, Inc. 2024 Q1 - Results - Earnings Call Presentation
        May 9 ETON Eton Pharmaceuticals GAAP EPS of -$0.03, revenue of $8M
        May 9 LSTA Lisata Therapeutics GAAP EPS of -$0.65 beats by $0.07
        May 9 LSTA Lisata Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
        May 9 ETON Eton Pharmaceuticals Reports First Quarter 2024 Financial Results
        May 9 CYTK Cytokinetics, Incorporated (NASDAQ:CYTK) Q1 2024 Earnings Call Transcript
        May 9 CYTK Cytokinetics Inc (CYTK) Q1 2024 Earnings Call Transcript Highlights: Navigating Through ...
        May 9 CYTK Cytokinetics, Incorporated (CYTK) Q1 2024 Earnings Call Transcript
        May 8 LSTA Lisata Therapeutics Q1 2024 Earnings Preview
        May 8 CYTK Cytokinetics (CYTK) Reports Q1 Loss, Lags Revenue Estimates
        May 8 CYTK Cytokinetics GAAP EPS of -$1.33 misses by $0.18, revenue of $0.84M misses by $0.07M
        May 8 CYTK Cytokinetics Reports First Quarter 2024 Financial Results
        May 8 ETON Eton Pharmaceuticals Q1 2024 Earnings Preview
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Biopharmaceutical Neuroscience Pharmaceutical Amyotrophic Lateral Sclerosis Biotechnology Disease Drug Design FDA Medicine Multiple Sclerosis Opioids Orphan Drug Pain Stroke Acid Addiction Adhd Alcohol Allergic Conjunctivitis Alzheimer's Disease
        U.S. Food And Drug Administration

        Browse All Tags